Allscripts (MDRX) Trys to Protect Against Unwanted Takeovers
Tweet
Share
E-mail
Get Alerts MDRX Hot Sheet
Join SI Premium – FREE
Traders have their eye on Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) Monday after the company adopted a poison bill. The adoption of the rights plan follows the massive sell-off in its stock price since April 26 and subsequent takeover rumors that have surrounded the name since that time.
Shares of Allscripts fell an astonishing 36 percent on April 27 after the company missed Q1 results, lowered FY12 outlook and announced that four directors and the CFO will leave.
While the company said the rights plan was not adopted in response to any current hostile takeover attempt, the company likely believes the vultures are circling.
Shares of Allscripts fell an astonishing 36 percent on April 27 after the company missed Q1 results, lowered FY12 outlook and announced that four directors and the CFO will leave.
While the company said the rights plan was not adopted in response to any current hostile takeover attempt, the company likely believes the vultures are circling.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- DOJ, TikTok settle for $400m in children's privacy suit - Axios
- Uber fined $966 Million in the Netherlands for automating driver suspensions - Reuters
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
